To establish clinical utility, we need to understand the consequences of extracellular volume (ECV) changes on cardiac function and adverse events, understand its incremental value compared with pre-and postprocedural clinical risk and serum biomarkers, and define how this knowledge will affect therapeutic management.
Department of Cardiology

Nieman, K., & Krestin, G. (2015). Science to practice: Collateral damage from percutaneous coronary intervention revealed: Can CT match MR imaging?. Radiology, 274(2), 309–310. Retrieved from